Spasticity Treatment Beyond Botulinum Toxins - 19/03/24
Doi : 10.1016/j.pmr.2023.06.009
Sheng Li, MD, PhD a, b, ⁎ 
, Paul Winston, MD c, d, Manuel F. Mas, MD e
, Paul Winston, MD c, d, Manuel F. Mas, MD e a Department of Physical Medicine and Rehabilitation, McGovern Medical School, University of Texas Health Science Center – Houston, Houston, TX, USA
b TIRR Memorial Herman
c Division of Physical Medicine and Rehabilitation, University of British Columbia, Victoria, British Columbia, Canada
d Canadian Advances in Neuro-Orthopedics for Spasticity Consortium, Victoria, British Columbia, Canada
e Department of Physical Medicine and Rehabilitation, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico
∗Corresponding author.
Résumé |
Botulinum toxin (BonT) is the mainstream treatment option for post-stroke spasticity. BoNT therapy may not be adequate in those with severe spasticity. There are a number of emerging treatment options for spasticity management. In this paper, we focus on innovative and revived treatment options that can be alternative or complementary to BoNT therapy, including phenol neurolysis, cryoneurolysis, and extracorporeal shock wave therapy.
Le texte complet de cet article est disponible en PDF.Keywords : Spasticity, Stroke, Phenol neurolysis, Cryoneurolysis, Extracorporeal shock wave therapy (ESWT)
Plan
© 2023
Elsevier Inc. Tous droits réservés.
Vol 35 - N° 2
P. 399-418 - mai 2024 Retour au numéro
Article précédent
- Technological Advances in Stroke Rehabilitation : Robotics and Virtual Reality
- Deepthi Rajashekar, Alexa Boyer, Kelly A. Larkin-Kaiser, Sean P. Dukelow
- A Review of Poststroke Aphasia Recovery and Treatment Options
- Victoria E. Tilton-Bolowsky, Argye E. Hillis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?